A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit

Endocrinology

Volumn 141, Issue 1, 2000, Pages 454-457

  Twigg, Stephen M ^a   Kiefer, Michael C ^b   Zapf, Jurgen ^c   Baxter, Robert C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; PROTEIN SUBUNIT; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CARBOXY TERMINAL SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 0034464846     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.1.7375     Document Type: Article

References (19)

1. Insulin-like growth factor (IGF) binding protein-5 forms an alternative ternary complex with IGFs and the acid-labile subunit
2. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human
3. Cloning and expression of growth hormone dependent insulin-like growth factor binding protein
4. Structural determinants of ligand and cell surface binding of insulin-like growth factor binding protein-3
5. Insulin-like growth factor binding protein-5 complexes with the acid-labile subunit: Role of the carboxyl-terminal domain
6. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5 and 6 produced in yeast
7. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum
8. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells
9. Human-osteoblast derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action
10. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane in osteoblastic cells
11. Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures
12. Glycosaminglycan binding characteristics of the insulin-like growth factor binding proteins
13. IGFBP-3 and IGFBP-5 association with endotheial cells: Role of the C-terminal heparin binding domain
14. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor binding protein complexes
15. Substitution of specific amino acids in insulin like growth factor (IGF) binding protein-5 alters heparin binding and its change in affinity for IGF-I response to heparin
16. Development, validation and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids
17. Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: A report of the Southwest Pediatric Nephrology Study Group
18. Isolation and characterization of circulating 13-kDa C-terminal fragments of human insulin-like growth factor binding protein-5
19. Molecular forms of human IGF binding proteins: Physiological implications